| Market Cap | 2M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -1.8M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 11.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -59.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -86.00% |
| Recommedations | - | Quick Ratio | 0.01 | Shares Outstanding | 2.84B | 52W Low Chg | 75.00% |
| Insider Own | - | ROA | -1,908.55% | Shares Float | 2.47B | Beta | 1.14 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00070 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 8,160,652 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 3,935,338 | Change | 0.00% |
VirExit Technologies, Inc. develops and provides antiviral technologies, personal protective equipment, and health and wellness products. It offers seated treadmills, nutraceuticals, and boutique style custom candles through its safer place market. The company was formerly known as Poverty Dignified, Inc. VirExit Technologies, Inc. was founded in 2013 and is headquartered in Richland, Washington.
